Triomics is an AI agents company for oncology electronic health records [1] based in New York City, NY, USA [2]. Founded in 2021, the company went through Y Combinator's Winter 2021 batch [3]. Triomics builds AI infrastructure for modern oncology by developing task-driven AI agents embedded directly into clinical workflows [5]. The platform automatically processes unstructured patient records such as pathology reports, clinical notes, genomic panels, and scanned faxes to support workflows including clinical trial matching, visit preparation, and quality reporting [5]. According to Y Combinator's directory, the company has a team size of 50 [4]. Triomics' platform is trusted by 4 of the top 10 Best Hospitals for Cancer ranked by U.S. News, as well as several of the largest community oncology practices [5].
Leadership & org chart
Alumni
- Regina SchwindVice President, Head of Clinical Data→Founding Scientific Advisor and Original IP Contributor at Sus Clinicals, Inc.
- Sebastien RhodesVice President of Strategy and Operations
About
- Triomics is building the AI infrastructure for modern oncology. Across the U.S., cancer care providers rely on highly trained staff to manually review unstructured patient records such as pathology reports, clinical notes, genomic panels, and scanned faxes to support workflows like clinical trial matching, visit preparation, and quality reporting. We replace that manual work with task-driven AI agents embedded directly into clinical workflows, automatically processing medical records at scale and in real time. Our platform is trusted by 4 of the top 10 Best Hospitals for Cancer ranked by U.S. News, as well as several of the largest community oncology practices.[5]
Something wrong or missing? Send a correction. Fixed within 24 hours.